Venkat Mocherla

So I think educating yourself in that all sorts of investors come in all shapes and sizes and knowing which one is the right fit for you is also, also goes a long way. Sorry, I didn't mean to mean to cut you off, but it's sometimes people.

So I think educating yourself in that all sorts of investors come in all shapes and sizes and knowing which one is the right fit for you is also, also goes a long way. Sorry, I didn't mean to mean to cut you off, but it's sometimes people.

Yeah, I mean, I think I'm really conflicted on this. On one side, I think absolutely you need to build a ethical business where you're very clear and transparent with your customer of what do you need the data for? How are you going to train the data?

Yeah, I mean, I think I'm really conflicted on this. On one side, I think absolutely you need to build a ethical business where you're very clear and transparent with your customer of what do you need the data for? How are you going to train the data?

And, you know, and where is the data going to go and what are all the safeguards behind that data set so that that the customer ultimately knows that you're not packaging that data and selling it to, you know, let's just say that if you're getting data from health systems and you're selling it to, you know, the life sciences companies, you're very clear about that business model and you're very clear about the process and the infrastructure you have to enable that in a very safe way.

And, you know, and where is the data going to go and what are all the safeguards behind that data set so that that the customer ultimately knows that you're not packaging that data and selling it to, you know, let's just say that if you're getting data from health systems and you're selling it to, you know, the life sciences companies, you're very clear about that business model and you're very clear about the process and the infrastructure you have to enable that in a very safe way.

So I think there's no ifs and buts on transparency and ethics around that at the same time scott i think i've seen multiple occasions where when the rules of the road have been defined before the as the as the space is sort of infant uh in its nature it's it's you know right now i think AI is still in the neonatal unit infancy.

So I think there's no ifs and buts on transparency and ethics around that at the same time scott i think i've seen multiple occasions where when the rules of the road have been defined before the as the as the space is sort of infant uh in its nature it's it's you know right now i think AI is still in the neonatal unit infancy.

I think we're in the early era of a multi-decade transformation that is fundamentally gonna be as revolutionary as driving with my mom and dad in the Mazda MPV using MapQuest or Triptych. to sitting in, you know, just yesterday they were in a Waymo car in San Francisco.

I think we're in the early era of a multi-decade transformation that is fundamentally gonna be as revolutionary as driving with my mom and dad in the Mazda MPV using MapQuest or Triptych. to sitting in, you know, just yesterday they were in a Waymo car in San Francisco.

I think that transformation is going to happen where autonomy in health care is possible and it's going to be incredibly revolutionary. But I just think we're in such early innings that I think in the name of I think what I've observed is

I think that transformation is going to happen where autonomy in health care is possible and it's going to be incredibly revolutionary. But I just think we're in such early innings that I think in the name of I think what I've observed is

The fastest way that big companies can crush little companies is they use safety as a cloaking mechanism, because they've got the policy teams, the K Street people in D.C. to be able to sort of say, hey, we could do this because we have an army of lawyers and we've got all the quote unquote experts. And so I think I'm sort of speaking of two sides of my...

The fastest way that big companies can crush little companies is they use safety as a cloaking mechanism, because they've got the policy teams, the K Street people in D.C. to be able to sort of say, hey, we could do this because we have an army of lawyers and we've got all the quote unquote experts. And so I think I'm sort of speaking of two sides of my...

I think it's like, you know, one, absolutely be incredibly transparent, invest in security, invest in safety. And I think, by the way, increasingly places like the Mayo Clinic and others are establishing frameworks where they can sort of understand the outcomes and efficacy of your algorithms, of your software in AI. So there's sort of gold standards of what's getting stamped.

I think it's like, you know, one, absolutely be incredibly transparent, invest in security, invest in safety. And I think, by the way, increasingly places like the Mayo Clinic and others are establishing frameworks where they can sort of understand the outcomes and efficacy of your algorithms, of your software in AI. So there's sort of gold standards of what's getting stamped.

And by the way, investors do a ton of diligence themselves. At the same time, when we're talking about sort of legislation and policy from DC, I also am sort of mindful of that as well. So there's sort of two sides of the coin.

And by the way, investors do a ton of diligence themselves. At the same time, when we're talking about sort of legislation and policy from DC, I also am sort of mindful of that as well. So there's sort of two sides of the coin.

I mean, my advice to founders is, Scott, I think this is like, boy, this is like one of the most exciting times to be in healthcare. I think, again, I've sort of, I have this,

I mean, my advice to founders is, Scott, I think this is like, boy, this is like one of the most exciting times to be in healthcare. I think, again, I've sort of, I have this,